BioSpace News Archive

Enzo Biochem, Inc., a leading biotechnology and diagnostic company, announced its wholly owned subsidiary, Enzo Clinical Labs, Inc., has expanded its screening services for COVID-19.

Scholar Rock announced an oral presentation on SRK-015, a highly specific inhibitor of the activation of latent myostatin, at the Muscular Dystrophy Association Clinical & Scientific Conference.

Windtree Therapeutics, Inc., a biotechnology and medical device company focused on developing drug product candidates and medical device technologies to address acute cardiovascular and pulmonary diseases, announced it is planning to study its proprietary KL4 surfactant to potentially mitigate the pulmonary effects of severe COVID-19 infection.

Avails Medical, a pioneer in automated, accelerated antibiotic susceptibility testing (AST) for septic patients announced today the participation of OMRON VENTURES Co., Ltd. in its current equity financing round.

Derm-Biome Pharmaceuticals, Inc, a private Vancouver based start-up biopharmaceutical company focused on skin health and healthy ageing, is pleased to announce that one of its topical drugs produced significant, and dose dependent inhibitory effects in a well established mouse model of atopic dermatitis (AD)

Menlo Therapeutics Inc. appointed Andrew Saik as Chief Financial Officer and Treasurer, effective March 23, 2020. Mr. Saik will report to David Domzalski, Chief Executive Officer, and will be responsible for leading the Company’s global finance operations, including, fi

Capricor Therapeutics (NASDAQ: CAPR), a clinical-stage biotechnology company focused on the development of first-in-class biological therapeutics for the treatment of Duchenne muscular dystrophy (DMD) and other rare disorders, today announced that it will host a Key Opinion Leader (KOL) call on why exosomes are uniquely suited for vaccine development on Thursday, March 26, 2020 at 12pm Eastern Time. The call will feature a presentation by K

Eli Lilly and Company (NYSE: LLY) today is providing updates related to insulin supply and affordability: As we announced on March 3 , Lilly does not currently anticipate shortages for any of our medicines, including all forms of insuli

IndieBio, the world’s most active investor in early stage life science startups, announces an immediate call for COVID-19 related applications. Up to 8 startups will rece

Epilepsy Foundation announced it has elected Brazilian-American fashion and beauty entrepreneur Camila Coelho to its Board of Directors.